gliclazide d4

Norfluoxetine-D5 hydrochloride is intended for use as an internal standard for the quantification of norfluoxetine by GC- or LC-MS. Norfluoxetine is an active metabolite of the antidepressant fluoxetine. It is formed from fluoxetine by the cytochrome P450 (CYP) isoforms CYP2C9, CYP2C19, and CYP3A. Norfluoxetine inhibits serotonin (5-HT) uptake in rat brain synaptosomal membrane preparations (Ki = 44.7 nM) and isolated human platelets (IC50 = ~15 nM). It has been found in the tissues of fish exposed to wastewater effluent.

Gliclazide-D4 is intended for use as an internal standard for the quantification of gliclazide by GC- or LC-MS. Gliclazide (T1527) is a sulfonylurea and an inhibitor of pancreatic β-cell ATP-sensitive potassium (KATP) channels. It is selective for pancreatic β-cell over cardiac and arterial smooth muscle cell KATP channels. Gliclazide (T1527) (5 μM) increases insulin-induced glucose uptake and glucose transporter 4 (GLUT4) translocation to the plasma membrane in a differentiated 3T3L1 adipocyte model of insulin resistance induced by hydrogen peroxide. Gliclazide (T1527) (5 and 10 μg/ml) reduces LDL oxidation by human aortic smooth muscle cells (HASMCs), decreasing TBARS content and 8-isoprostane levels. It also decreases oxidized LDL-induced HASMC proliferation and monocyte adhesion when used at concentrations ranging from 1 to 10 μg/ml. Gliclazide (T1527) (5 mg/kg) reduces serum glucose levels and increases glucose uptake by isolated rat hindquarters in a model of diabetes induced by streptozotocin (STZ).

Gliclazide-D4 (Standard) is a reference standard of Gliclazide-D4 intended for quantitative analysis, quality control, and related biochemical research applications. Gliclazide-d4 is used as an internal standard when quantitatively analyzing Gliclazide by gas chromatography-mass spectrometry or liquid chromatography-mass spectrometry. Gliclazide is a sulfonylurea drug that can inhibit the ATP-sensitive potassium (KATP) channels of pancreatic β cells. It has a higher selectivity for pancreatic β cells than for the KATP channels of cardiac and arterial smooth muscle cells.